Page last updated: 2024-12-07

1,2-di-o-tetradecyl-3-o-(glucopyranosyl)glycerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2-di-O-tetradecyl-3-O-(glucopyranosyl)glycerol, also known as **glucosyldiglyceride (GDG)**, is a type of glycolipid.

Here's a breakdown of its structure and importance:

**Structure:**

* **Glycerol backbone:** The molecule is based on a glycerol molecule, a three-carbon alcohol.
* **Fatty acid chains:** Two long-chain fatty acids, specifically tetradecanoic acid (myristic acid), are attached to the first two carbons of the glycerol backbone. These are known as tetradecyl groups.
* **Sugar moiety:** A glucose molecule, in its pyranose ring form (glucopyranosyl), is attached to the third carbon of the glycerol backbone.

**Importance in Research:**

GDG plays a significant role in various fields of research:

* **Biology and Cell Signaling:**
* **Membrane structure:** GDG is a major component of cell membranes, particularly in plant cells. It influences membrane fluidity, permeability, and the function of embedded proteins.
* **Signal transduction:** GDG acts as a second messenger in various cellular processes. It can activate enzymes involved in lipid metabolism, stress responses, and cell growth.
* **Plant development:** GDG is crucial for plant development, impacting processes like germination, leaf formation, and response to environmental stimuli.

* **Biochemistry and Lipid Metabolism:**
* **Synthesis and degradation:** Understanding the biosynthesis and degradation pathways of GDG helps researchers study lipid metabolism in plants and other organisms.
* **Metabolic disorders:** Alterations in GDG levels are linked to various metabolic disorders in plants and animals, making it a target for further investigation.

* **Food science and biotechnology:**
* **Food production:** GDG is present in certain foods, influencing their texture and flavor.
* **Bioactive compounds:** GDG has potential health benefits and is being explored for its use in functional foods and nutraceuticals.
* **Biofuel production:** GDG can be utilized as a precursor for biofuel production, contributing to sustainable energy sources.

**Overall, 1,2-di-O-tetradecyl-3-O-(glucopyranosyl)glycerol (GDG) is a fascinating molecule with diverse roles in biology, biochemistry, and applied fields. Research into its structure, function, and applications continues to uncover valuable insights into cellular processes and potential technological advancements.**

1,2-di-O-tetradecyl-3-O-(glucopyranosyl)glycerol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133646
MeSH IDM0146291

Synonyms (6)

Synonym
alpha-d-glucopyranoside, 2,3-bis(tetradecyloxy)propyl-, (r)-
1,2-di-o-tetradecyl-3-o-(glucopyranosyl)glycerol
alpha-dtgl
1,2-tdgg
81281-22-3
(2s,3r,4r,5r,6r)-6-(hydroxymethyl)-2-propoxy-3,4-di(tetradecoxy)oxane-3,4,5-triol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]